This is an old revision of this page, as edited by 74.234.165.43 (talk) at 14:46, 12 May 2010. The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 14:46, 12 May 2010 by 74.234.165.43 (talk)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)K2 is a herbal smoking blend made of herbs and spices sprayed with synthetic cannabinoids (notably JWH-018), which mimic the effects of cannabis. It is produced in China and Korea. It can be consumed in ways comparable to cannabis.
It is a product similar to Spice K2 comes in many varieties with names such as Blonde, Summit, Standard, and Citron. No official studies have been conducted on its effects on humans. Though its effects are not well documented, it may cause negative effects that are not noted in marijuana users, such as increased agitation and vomiting.
It is legal and readily available throughout most of the United States. Its use has sparked alarm in several states including Kansas and Kentucky which have banned the sale and possession of its active chemicals, and the town council of St. Charles, Missouri has passed emergency legislation banning its sale. Springdale, Arkansas and the surrounding area have also banned K2. The US Army has banned soldier use. The substance as recently been banned in Missouri following in Kansas's footsteps.
Many users say its effects are even stronger than that of Cannabis.
References
First hand description, directions, and comparison to marijuana at <http://lettergram.org/?p=282>
- "Drug profile: Synthetic cannabinoids and 'Spice'". EMCDDA Drug Profiles. European Monitoring Centre for Drugs and Drug Addiction. 2009. Retrieved 2010-04-21.
- "International K2 Incense Orders". K2 Incense. 2010. Retrieved 2010-04-21.
- ^ "Fake pot that acts real stymies law enforcement". The Associated Press. 2010-02-17. Retrieved 2010-04-21.
- Jeanna Bryner (2010-03-03). "Fake Weed, Real Drug: K2 Causing hallucinations in Teens". LiveScience. Retrieved 2010-04-21.